Neural tube defects: from a proteomic standpoint.

Area of Science:

• Developmental Biology
• Medical Genetics
• Biochemistry

Background:

• Neural tube defects (NTDs) are congenital birth defects diagnosed primarily through ultrasound.
• Genetic studies have identified numerous genes involved in NTDs, but their functions are often unclear.
• Current diagnostic methods lack comprehensive biochemical characterization.

Purpose of the Study:

• To review the application of proteomics in identifying novel biomarkers for NTDs.
• To explore the potential of proteomics in elucidating molecular networks involved in NTDs.
• To highlight the importance of proteomic advancements for improved patient management.

Main Methods:

• Review of existing literature on proteomics and NTDs.
• Analysis of mass spectrometry-based approaches for biomarker discovery.
• Integration of data from clinical samples and animal models.

Main Results:

• Proteomics enables the identification of novel protein and metabolic biomarkers.
• Mass spectrometry facilitates a deeper understanding of molecular cascades in NTDs.
• Advancements in proteomics offer new avenues for early detection and diagnosis.

Conclusions:

• Proteomics is crucial for discovering new biomarkers and molecular networks in NTDs.
• This approach can significantly enhance the understanding and clinical management of NTDs.
• Further research in proteomics will be indispensable for improving patient outcomes.